Bank Of New York Mellon Corp Emergent Bio Solutions Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$7.79 - $16.29 $3.93 Million - $8.21 Million	504,039 New	504,039 $5.22 Billion
Q4 2022 Feb 14, 2023	BUY	$11.0 - $21.45 $5.76 Million - $11.2 Million	523,680 New	523,680 $6.18 Million
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $7,835 - $13,961	390 Added 0.08%	482,164 $10.1 Million
Q2 2022 Aug 15, 2022	SELL	$27.42 - $43.63 $2.95 Million - $4.69 Million	-107,505 Reduced 18.24%	481,774 $15 Million
Q1 2022 May 11, 2022	SELL	$36.48 - $52.22 $58,659 - $83,969	-1,608 Reduced 0.27%	589,279 $24.2 Million
Q4 2021 Feb 11, 2022	SELL	$33.11 - $55.01 $109,296 - $181,588	-3,301 Reduced 0.56%	590,887 $25.7 Million
Q3 2021 Nov 12, 2021	BUY	$50.07 - $66.05 $3.59 Million - $4.74 Million	71,731 Added 13.73%	594,188 $29.8 Million
Q2 2021 Aug 11, 2021	BUY	$56.61 - $80.46 $971,597 - $1.38 Million	17,163 Added 3.4%	522,457 $32.9 Million
Q1 2021 May 13, 2021	SELL	$86.23 - $125.19 $1.29 Million - $1.87 Million	-14,922 Reduced 2.87%	505,294 $46.9 Million
Q4 2020 Feb 09, 2021	SELL	$79.17 - $111.47 $1.44 Million - $2.03 Million	-18,214 Reduced 3.38%	520,216 $46.6 Million
Q3 2020 Nov 12, 2020	SELL	$81.91 - $134.94 $103,042 - $169,754	-1,258 Reduced 0.23%	538,430 $55.6 Million
Q2 2020 Aug 12, 2020	BUY	$54.33 - $89.52 $551,232 - $908,269	10,146 Added 1.92%	539,688 $42.7 Million
Q1 2020 May 06, 2020	SELL	$49.34 - $68.76 $1.19 Million - $1.66 Million	-24,149 Reduced 4.36%	529,542 $30.6 Million
Q4 2019 Feb 14, 2020	SELL	$51.21 - $59.06 $1.51 Million - $1.74 Million	-29,458 Reduced 5.05%	553,691 $29.9 Million
Q3 2019 Nov 07, 2019	SELL	$40.6 - $57.2 $988,731 - $1.39 Million	-24,353 Reduced 4.01%	583,149 $30.5 Million
Q2 2019 Aug 12, 2019	SELL	$39.92 - $53.86 $6.77 Million - $9.13 Million	-169,489 Reduced 21.81%	607,502 $29.3 Million
Q1 2019 May 14, 2019	SELL	$48.23 - $66.16 $993,682 - $1.36 Million	-20,603 Reduced 2.58%	776,991 $39.3 Million
Q4 2018 Feb 11, 2019	SELL	$55.63 - $73.24 $3.02 Million - $3.97 Million	-54,246 Reduced 6.37%	797,594 $47.3 Million
Q3 2018 Nov 09, 2018	BUY	$52.05 - $66.51 $4.99 Million - $6.38 Million	95,892 Added 12.68%	851,840 $0
Q2 2018 Aug 06, 2018	BUY	$48.33 - $55.64 $811,992 - $934,807	16,801 Added 2.27%	755,948 $38.2 Million
Q1 2018 May 15, 2018	BUY	$44.44 - $54.39 $7.36 Million - $9.01 Million	165,697 Added 28.89%	739,147 $38.9 Million
Q4 2017 Feb 09, 2018	BUY	$37.77 - $47.75 $21.7 Million - $27.4 Million	573,450	573,450 $26.6 Million

Others Institutions Holding EBS

# of Institutions

159

Shares Held

33.7M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$36.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$32.2 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$23.6 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$21.1 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$18.1 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $473M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account